A fully integrated point-of-care test for ebola

Ended Grant Awarded Last action

Award ID
R01AI150888
Recipient
Awarding agency
Obligated
$3,384,751

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Place of performance
North Carolina, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$2,675
Amendment $590,199
Amendment $590,199
Amendment $772,176
Amendment $717,426
Original award $717,426

Subawards

Subrecipient Amount Awarded
University Of Texas Medical Branch At Galveston Specific Aims: This subcontract will support Aim 3. SA3 – In vitro validation of the D4 assay in biologically relevant matrixes and testing with… $74,759
Biostealth Inc. Biostealth will provide the chips required to complete this project and develop a transition from laser cut chips to higher volume manufacturing techniques,… $120,000

Quick answers

Who received award R01AI150888?

R01AI150888 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 23, 2020.

How much is award R01AI150888 worth?

$3,384,751 has been obligated on R01AI150888.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award